Rapid Micro Biosystems

IPO

Automated Quality Control Microbiology

Public · Lowell, United States · $217.2M raised

Employees
51–200
Business Model
B2B
Total Funding
$217.2M
Last Round
$25.0M Series CMar 2021
Rounds
5
Type
Public

About

Develops automated microbiology quality control systems for biomanufacturing, enabling fast and accurate microbial contamination detection.

Summary

Rapid Micro Biosystems is a Biotech company based in Lowell, United States. It has raised $217.2M in total across 5 rounds, most recently a $25.0M Series C round in Mar 2021. Investors include Bain Capital Life Sciences, MLS Capital Fund II and D1 Capital Partners.

Tech & App Stack

8 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Growth EquityGrowth EquityMar 2021
$81.0M

Sign up to see all 5 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies